Birth defects: from molecules to mechanisms

A J Copp1

  • 1Hospital for Sick Children, London.

Insights

Understanding birth defects requires studying gene mutations in animal models and analyzing embryonic development. This research combines genetic and embryological approaches to uncover causes and preventions for birth defects.

Area of Science:

  • Developmental biology
  • Genetics
  • Teratology

Background:

  • Birth defects are a significant clinical challenge with limited primary prevention strategies.
  • Rudimentary understanding of embryonic mechanisms hinders effective prevention of birth defects.
  • Advances in molecular biology enable identification of genes predisposing to birth defects.

Purpose of the Study:

  • To explore the genetic and embryonic mechanisms underlying birth defects.
  • To evaluate the utility of gene targeting and experimental embryology in studying birth defect pathogenesis.
  • To advance the understanding of genetically determined birth defects through integrated research.

Main Methods:

  • Genetic analysis of animal models, particularly mice, with known genetic mutations.
  • Gene targeting techniques to induce mutations and evaluate their role in birth defect development.
  • In vitro culture of intact mouse and rat embryos to study embryonic development.
  • Experimental embryological analysis to elucidate downstream pathogenetic events.

Main Results:

  • Identified specific genes associated with heritable predisposition to birth defects.
  • Demonstrated the effectiveness of gene targeting in evaluating potential birth defect-inducing genes.
  • Elucidated steps in the embryonic development of genetically determined spina bifida using in vitro embryo culture.

Conclusions:

  • Combining gene-centered and embryo-centered research is crucial for understanding birth defect pathogenesis.
  • Animal models and advanced molecular techniques are vital tools for investigating birth defects.
  • Further research integrating genetic and embryological approaches promises significant advancements in preventing birth defects.

Related Concept Videos

Mutations01:39

Mutations

Overview
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...